Article
Fidaxomicin jams <i>M. tuberculosis</i> RNA polymerase motions needed for initiation via RbpA contacts
2018-01-08
Abstract excerpt
Fidaxomicin (Fdx) is an antimicrobial RNA polymerase (RNAP) inhibitor highly effective against Mycobacterium tuberculosis RNAP in vitro , but clinical use of Fdx is limited to treating Clostridium difficile intestinal infections due to poor absorption. To enable structure-guided optimization of Fdx to treat tuberculosis, we report the 3.4 Å cryo-electron microscopy structure of a complete M. tuberculosis RNAP...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- eff18e01-01b8-5dad-b215-57b3dde50dd9
- DOI
- 10.1101/244533
